Guidelines for optimal management of diabetes advocate comprehensive strategies to treat all established risk factors for coronary heart disease (CHD). The targets for treatment should be optimization of glycemie control, weight reduction, lowering of elevated blood pressure, correction of lipid abnormalities, and stopping smoking. Recently, strong evidence has emerged to demonstrate that poor glycemic control is a powerful predictor for excess CHD risk (1,2). The fact that dyslipidemia and hypertension are frequent in NIDDM patients at the time of diagnosis indicates that these risk factors may cause damage for years before the actual diagnosis of NIDDM. This article highlights the current background knowledge for the guidelines of therapeutic strategies for dyslipidemias in NIDDM.
Skip Nav Destination
Article navigation
FUTURE STRATEGIES FOR THE PREVENTION OF AND THERAPY FOR MACROVASCULAR COMPLICATIONS|
July 01 1996
Criteria for Metabolic Control and Intervention in Diabetes
Marja-Riitta Taskinen
Marja-Riitta Taskinen
Department of Medicine, University of Helsinki
Helsinki, Finland
Search for other works by this author on:
Address correspondence and reprint requests to Dr. Marja-Riitta Taskinen, Department of Medicine, University of Helsinki, Haartmaninkatu 4, FIN-00290 Helsinki, Finland
Diabetes 1996;45(Supplement_3):S120–S122
Article history
Accepted:
September 26 1995
PubMed:
8674877
Citation
Marja-Riitta Taskinen; Criteria for Metabolic Control and Intervention in Diabetes. Diabetes 1 July 1996; 45 (Supplement_3): S120–S122. https://doi.org/10.2337/diab.45.3.S120
Download citation file: